Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "centre"

1047 News Found

Krsnaa Diagnostics public issue opens from Aug 4-6th 2021
Healthcare | August 02, 2021

Krsnaa Diagnostics public issue opens from Aug 4-6th 2021

Price band in the range of Rs 933 to Rs 954


Lupin donates Oxygen generation plants in Mah, MP & Gujarat
News | June 12, 2021

Lupin donates Oxygen generation plants in Mah, MP & Gujarat

These five oxygen plants with a total capacity of 3,840 cubic meters of oxygen per day have been donated to Madhya Pradesh, Maharashtra, and Gujarat


India aims to vaccinate 1 crore people every day
News | June 12, 2021

India aims to vaccinate 1 crore people every day

India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021


Lupin receives U.S. FDA approval for HIV-1 drug
Pharma | June 08, 2021

Lupin receives U.S. FDA approval for HIV-1 drug

Emtricitabine and Tenofovir Disoproxil Fumarate tablets had estimated annual sales of US $2.1 billion in the U.S. according to IQVIA MAT March 2021


Haffkine Biopharma to produce 22.8 Cr doses of Covaxin
News | June 03, 2021

Haffkine Biopharma to produce 22.8 Cr doses of Covaxin

For undertaking production, the company has been provided a Rs. 65 crore grant by the centre and Rs. 94 crore from the government of Maharashtra


Bharat Biotech signs MoU with GCVC for COVID Vaccine
News | May 28, 2021

Bharat Biotech signs MoU with GCVC for COVID Vaccine

It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN


Govt. to augment Covaxin production by 10 crore doses
News | May 16, 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India


Gap between two doses of Covishield extended; No extension for Covaxin
News | May 14, 2021

Gap between two doses of Covishield extended; No extension for Covaxin

The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield


DCGI approves anti-COVID drug developed by DRDO
Policy | May 10, 2021

DCGI approves anti-COVID drug developed by DRDO

The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production


Morepen Laboratories net profit up 189%
News | May 05, 2021

Morepen Laboratories net profit up 189%

R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices